Distribution of risk categories and symptom timing (IMAGE)
Caption
Panel (A) shows classifications based on the ASCVD Risk Estimator Plus, where 45% (209/465) of patients would not have qualified for statin therapy or further testing. Panel (B) displays results from the PREVENT calculator, which classified an even larger proportion—61% (285/465)—as low or borderline risk despite subsequent MI. Panel (C) shows timing of symptom onset, with 279 patients (60%) developing symptoms within 48 hours of presentation.
Credit
Mount Sinai Health System
Usage Restrictions
Use with credit
License
Original content